BioSpace News Archive

Business

Jaguar Health to Host Earnings Conference Call Tuesday, November 14th at 4:30 p.m. Eastern Time

Jaguar Health announced today that it will host a conference call on Tuesday, November 14, 2017 at 4:30 p.m. Eastern Time to review year-to-date sales figures for Jaguar and Napo Pharmaceuticals, Inc. (Napo).

November 9, 2017
·
5 min read
Business

Ossur Hf: Management Changes

Kim de Roy has been appointed EVP of R&D and will become a member of Össur’s Executive Management.

November 9, 2017
·
1 min read
Business

Histogenics Corporation Announces Third Quarter 2017 Financial and Operating Results

Loss from operations was $(5.7) million in the third quarter of 2017, compared to $(6.6) million in the third quarter of 2016.

November 9, 2017
·
9 min read
Business

Catalyst Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides Corporate Update

For the quarter ended September 30, 2017, Catalyst reported a GAAP net loss of $4,177,649, or $0.05 per basic and diluted share, compared to a GAAP net loss of $3,953,981.

November 9, 2017
·
11 min read
Business

Thermo Fisher Declares Quarterly Dividend

Thermo Fisher Scientific today announced that its board of directors declared a quarterly cash dividend of $0.15 per share

November 9, 2017
·
1 min read
Policy

New SAFE-BioPharma Standard Trust List Enables Validation of Digital Signatures in Both US and EU

A newly published SAFE-BioPharma Trust List vastly improves workflows involving sensitive and proprietary electronic documents exchanged between the US and the EU.

November 9, 2017
·
1 min read
Business

Qu Biologics Recruits Ms. Jennifer Archibald, Chief Financial Officer, and Mr. Alun Rees, VP, Manufacturing, to Leadership Team

Ms. Jennifer Archibald has joined Qu Biologics in the role of Chief Financial Officer (CFO) to head up the company’s financial and accounting operations.

November 9, 2017
·
5 min read
Business

Adamas Announces New Employment Inducement Grant - Nov. 9, 2017

The company’s board of directors granted five new employees the option to purchase an aggregate of 15,300 shares of the company’s common stock, at a per share exercise price of $27.00.

November 9, 2017
·
1 min read
Business

Crown Bioscience Announcing the 2017 Board of Directors Election Results

Dr. Guoliang Yu re-elected as the Chairman.

November 9, 2017
·
2 min read
Genetown

Sarepta Therapeutics Prices $475M of Convertible Senior Notes Due 2024

Chief executive officer purchases approximately $2 million of shares of Sarepta’s common stock.

November 9, 2017
·
7 min read